JP4446592B2 - 液体試料測定ユニット及びそれを備えた自動液体試料分析装置 - Google Patents
液体試料測定ユニット及びそれを備えた自動液体試料分析装置 Download PDFInfo
- Publication number
- JP4446592B2 JP4446592B2 JP2000392928A JP2000392928A JP4446592B2 JP 4446592 B2 JP4446592 B2 JP 4446592B2 JP 2000392928 A JP2000392928 A JP 2000392928A JP 2000392928 A JP2000392928 A JP 2000392928A JP 4446592 B2 JP4446592 B2 JP 4446592B2
- Authority
- JP
- Japan
- Prior art keywords
- light
- liquid sample
- container
- light source
- measurement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000005259 measurement Methods 0.000 title claims description 69
- 239000007788 liquid Substances 0.000 title claims description 28
- 239000003153 chemical reaction reagent Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 21
- 230000023555 blood coagulation Effects 0.000 claims description 16
- 239000000758 substrate Substances 0.000 claims description 13
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 239000000523 sample Substances 0.000 description 66
- 239000003154 D dimer Substances 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 108010052295 fibrin fragment D Proteins 0.000 description 12
- 230000032258 transport Effects 0.000 description 12
- 108090000935 Antithrombin III Proteins 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 11
- 102100022977 Antithrombin-III Human genes 0.000 description 10
- 239000012470 diluted sample Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000007599 discharging Methods 0.000 description 5
- 238000009434 installation Methods 0.000 description 5
- 102000013566 Plasminogen Human genes 0.000 description 4
- 108010051456 Plasminogen Proteins 0.000 description 4
- 102000003801 alpha-2-Antiplasmin Human genes 0.000 description 4
- 108090000183 alpha-2-Antiplasmin Proteins 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108010058861 Fibrin Fibrinogen Degradation Products Proteins 0.000 description 3
- 239000012459 cleaning agent Substances 0.000 description 3
- 239000000208 fibrin degradation product Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 238000011325 biochemical measurement Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical class CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- VYLJFJGMPYBPMN-VXKWHMMOSA-N (2s)-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-[2-[(4-methylphenyl)sulfonylamino]acetyl]pyrrolidine-2-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC=2C=CC(=CC=2)[N+]([O-])=O)CCC1 VYLJFJGMPYBPMN-VXKWHMMOSA-N 0.000 description 1
- 102000004411 Antithrombin III Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960005348 antithrombin iii Drugs 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 108010018472 chromozym TH Proteins 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- QQVNCBCBFNWLJX-KCHLEUMXSA-N n-[(2s)-1-[[(2s)-1-[[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]benzamide Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)NC(=O)C=1C=CC=CC=1)C1=CC=CC=C1 QQVNCBCBFNWLJX-KCHLEUMXSA-N 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Optical Measuring Cells (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000392928A JP4446592B2 (ja) | 2000-12-25 | 2000-12-25 | 液体試料測定ユニット及びそれを備えた自動液体試料分析装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000392928A JP4446592B2 (ja) | 2000-12-25 | 2000-12-25 | 液体試料測定ユニット及びそれを備えた自動液体試料分析装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002196007A JP2002196007A (ja) | 2002-07-10 |
| JP2002196007A5 JP2002196007A5 (enrdf_load_stackoverflow) | 2008-02-07 |
| JP4446592B2 true JP4446592B2 (ja) | 2010-04-07 |
Family
ID=18858838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000392928A Expired - Fee Related JP4446592B2 (ja) | 2000-12-25 | 2000-12-25 | 液体試料測定ユニット及びそれを備えた自動液体試料分析装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4446592B2 (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105974142A (zh) * | 2016-05-13 | 2016-09-28 | 长春迪瑞医疗科技股份有限公司 | 一种多光路凝血分析系统 |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4170189B2 (ja) * | 2003-10-02 | 2008-10-22 | 株式会社アペレ | 比色計等の測定セルおよびその使用方法 |
| JP4505230B2 (ja) * | 2004-01-20 | 2010-07-21 | シスメックス株式会社 | 分析装置 |
| CN1320350C (zh) * | 2004-07-06 | 2007-06-06 | 武汉市华中电测技术开发有限公司 | 凝血功能系统检测装置 |
| JP4753645B2 (ja) * | 2005-07-11 | 2011-08-24 | ベックマン コールター， インコーポレイテッド | 自動分析装置 |
| EP3421969A1 (en) | 2005-07-27 | 2019-01-02 | Sysmex Corporation | Cuvette |
| JP4829716B2 (ja) | 2006-08-18 | 2011-12-07 | シスメックス株式会社 | 血液凝固分析装置 |
| KR100886914B1 (ko) * | 2007-11-01 | 2009-03-09 | 주식회사 아이센스 | 혈액 분석 장치용 카트리지 및 이를 이용한 혈액 분석 장치 |
| SE532617C2 (sv) * | 2007-11-13 | 2010-03-02 | Lifeassays Ab Publ | Spolmekanism för magnetisk detektor |
| KR100940310B1 (ko) * | 2007-12-12 | 2010-02-05 | 전남대학교산학협력단 | 다채널 형광검출장치 |
| KR100948810B1 (ko) * | 2008-04-08 | 2010-03-24 | 전남대학교산학협력단 | 다채널 생물반응기 온라인 모니터링장치 |
| JP5748782B2 (ja) * | 2011-01-21 | 2015-07-15 | 株式会社日立ハイテクノロジーズ | 自動分析装置 |
| JP5953129B2 (ja) * | 2012-06-04 | 2016-07-20 | 株式会社日立ハイテクノロジーズ | 自動分析装置 |
| JP6581483B2 (ja) * | 2015-11-27 | 2019-09-25 | シスメックス株式会社 | 検体分析装置 |
| JP6813953B2 (ja) * | 2016-02-29 | 2021-01-13 | シスメックス株式会社 | 血液凝固分析装置および血液凝固分析方法 |
| EP4045906A4 (en) * | 2019-10-17 | 2023-07-26 | Nova Biomedical Corporation | Coagulation assay apparatus and methods thereof |
| CN111122464B (zh) * | 2019-11-21 | 2022-07-05 | 哈尔滨医科大学 | 10微升血清碘测定仪的恒温光电池组件 |
-
2000
- 2000-12-25 JP JP2000392928A patent/JP4446592B2/ja not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105974142A (zh) * | 2016-05-13 | 2016-09-28 | 长春迪瑞医疗科技股份有限公司 | 一种多光路凝血分析系统 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002196007A (ja) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4446592B2 (ja) | 液体試料測定ユニット及びそれを備えた自動液体試料分析装置 | |
| US11693019B2 (en) | Automated liquid-phase immunoassay apparatus | |
| US9316583B2 (en) | Specimen analyzing method and specimen analyzing apparatus | |
| US7854891B2 (en) | Method of specimen analysis and specimen analyzer | |
| US20180267069A1 (en) | Sample analyzer | |
| US10416179B2 (en) | Automatic analyzer | |
| US8064061B2 (en) | Sample analyzer and sample analyzing method | |
| US5646049A (en) | Scheduling operation of an automated analytical system | |
| US6190617B1 (en) | Sample container segment assembly | |
| US5507410A (en) | Meia cartridge feeder | |
| US5627522A (en) | Automated liquid level sensing system | |
| KR20060035770A (ko) | 자동화된 다중 탐지 분석기 | |
| US9285311B2 (en) | System for performing scattering and absorbance assays | |
| WO2007139212A1 (ja) | 自動分析装置 | |
| KR102321031B1 (ko) | 자성 비드를 이용한 액상 면역반응 분석장치 | |
| WO2007135923A1 (ja) | 自動分析装置 | |
| JP2009150693A (ja) | 反応の良否判定方法及び分析装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071217 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071217 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091005 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091009 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091202 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100105 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100119 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130129 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130129 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160129 Year of fee payment: 6 |
|
| LAPS | Cancellation because of no payment of annual fees |